Sort   by:  
 Page size 
UnknownA Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
Not available
S-EPMC6334626 | biostudies-literature
UnknownAssessment of fatal cardiovascular disease risk using data-driven diabetes subgroups and SCORE2-Diabetes in 24,943 adults in Mexico City.
Not available
S-EPMC12724152 | biostudies-literature
UnknownComparison of low eGFR prevalence and prediction for mortality using 2009 and 2021 CKD-EPI equations in Mexican adults.
Not available
S-EPMC12258768 | biostudies-literature
UnknownOral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project OB12).
Not available
S-EPMC3403849 | biostudies-literature
UnknownEfficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Not available
S-EPMC11833520 | biostudies-literature
UnknownDevelopment of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Not available
S-EPMC10214179 | biostudies-literature
UnknownDifferentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.
Not available
S-EPMC11408082 | biostudies-literature
UnknownOlfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort.
Not available
S-EPMC12464792 | biostudies-literature
UnknownCNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Not available
S-EPMC11833661 | biostudies-literature
UnknownPridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Not available
S-EPMC11833658 | biostudies-literature
Sort   by:  
 Page size